HTLV-1

Findings by UMN Researchers Could Help Fight Cancer

December 20, 2018

Interdisciplinary researchers from the Institute for Molecular Virology (IMV) have made a key discovery that could help fight Human T-cell leukemia virus type (HTLV-1).

HTLV-1 is a rare but extremely infectious virus spreading among remote areas of central Australia. The virus produces particles that can then spread to other cells in the body. University of Minnesota researchers, including Louis Mansky, PhD, director of the IMV and professor in the School of Dentistry, and his team, created mutations in HTLV-1’s main structural protein (called Gag) and investigated how these mutants affected the production of HTLV-1 particles.

“By creating these mutants, we found important new insights regarding how the structure of the Gag protein is critically important in making new virus particles,” said Mansky, the lead author of the study.

Read the full story.

Other News

Interior of MIDB facility
The ability to connect with people from other areas takes our own work to a higher level and makes an impact on our communities.
UMN health sciences learners at Itasca Biological Station
Participation in the Itasca Ecohealth IPE Experience serves as part of the 1Health interprofessional education curriculum.
IPE inters 2023
The theme of this year’s program is to work in cooperation with those who receive and provide care.